ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
нет
1. Duan Z.J., Li L.L., Ju J., Gao Z.H., He G.H. Treatment of hyperbilirubinemia with blood purification in China. // World J Gastroenterol. – 2006. – Vol. 12(46) – P.7467-74712. Bambauer R., Latza R., Schiel R. Therapeutic Plasma Exchange and Selective Plasma Separation Methods // Pabst Science Publishers – Lengerich, 2013. - Р.42-4, 313-3183. Briz O., Serrano M.A., MacIas R.I., Gonzalez-Gallego J., Marin J.G. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. // Biochem J. 2003 – №371(Pt 3) – P.897-9054. Cui Y., König J., Leier I., Buchholz U., Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. // J Biol Chem. 2001 – №276(13) – P. 9626-96305. Krishnamurthy G.T., Krishnamurthy S. Cholescintigraphic measurement of liver function: how is it different from other methods? // Eur J Nucl Med Mol Imaging. 2006 – Vol. 33(10) – P. 1103-11066. Tanaka Y., Chen C., Maher J.M., Klaassen C.D. Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion. // Transplantation. – 2006. – Vol. 82(2) – P.258-2667. Stockmann H, Hiemstra CA, Marquet RL, Jzermans J. Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg 2000;231: 460–4708. Tomiya T, Nagoshi S, Fujiwara K. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992;15:1–49. Еремеева Л.Ф., Ямпольский А.Ф., Заболотских И.Б., Менщиков В.В. Гемостаз в условиях MARS-терапии и плазмосорбции у больных с печеночно-клеточной недостаточностью. Общая реаниматология. 2010; 6 (5): 35. DOI: 10.15360/1813- 9779-2010-5-3510. Исмаилов Е.Л., Ералина С.Н., Текесбаев Б.Б., Абдрасулов Р.Б. Методы экстракорпоральной детоксикации в лечении деструктивного панкреатита. Общая реаниматология. 2015; 11 (3): 65–74. DOI: 10.15360/1813-9779-2015-3-65-7411. Ямпольский М.А., Заболотских И.Б., Ямпольский А.Ф. Элиминация низкомолекулярных белков у больных с изолированной острой почечной недостаточностью. Общая реаниматология. 2010; 6 (5): 40. DOI: 10.15360/1813-9779-2010-5-4012. Larsen F.S. Artificial liver support in acute and acute-on-chronic liver failure. Curr Opin Crit Care. 2019; 25 (2): 187–191. DOI: 10.1097/MCC.000000000000058413. Tsipotis E., Shuja A., Jaber B.L. Albumin Dialysis for Liver Failure: A Systematic Review. Adv Chronic Kidney Dis. 2015; 22 (5): 382–390. DOI: 10.1053/j.ackd.2015.05.00414. García Martínez J.J., Bendjelid K. Artificial liver support systems: what is new over the last decade? Ann Intensive Care. 2018; 8 (1): 109. Published 2018 Nov 15. DOI: 10.1186/s13613-018-0453-z)15. Allard MA, Adam R, Bucur PO, Termos S, Cunha AS, Bismuth H, et al. Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg 2013;258:822-829; discussion 829-830.16. Fan M, Wang X, Xu G, Yan Q, Huang W. Bile acid signaling and liver regeneration. Biochim Biophys Acta 2015;1849:196-200.17. Simpson KJ, Lukacs NW, Colletti L, Strieter RM, Kunkel SL. Cytokines and the liver. J Hepatol 1997;27:1120-1132.18. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.19. Dello SA, Bloemen JG, van de Poll MC, van Dam RM, Stoot JH, van den Broek MA, et al. Gut and liver handling of interleukin-6 during liver resection in man. HPB (Oxford) 2011;13:324-331.20. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 2003;38:674-682.21. Donati G, La Manna G, Cianciolo G, Grandinetti V, Carretta E, Cappuccilli M, et al. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. Artif Organs 2014;38:125-134.22. Dominik A, Stange J, Pfensig C, Borufka L, Weiss-Reining H, Eggert M. Reduction of elevated cytokine levels in acute/acute- on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study. Ther Apher Dial 2014;18:347-352.23. Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, et al. MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study. Scand J Gastroenterol 2009;44:745-751.24. Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg 2011;98:623-631.25. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-828; discussion 828-829.26. Sparrelid E, Gilg S, van Gulik TM. Systematic review of MARS treatment in post-hepatectomy liver failure. HPB (Oxford) 2020;22:950-960.